X
KRTX

Xponance’s Karuna Therapeutics, Inc. Common Stock KRTX Stock Holding History

Xponance’s Portfolio KRTX Stock Details KRTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-4,432
Closed -$1.4M – 1330
2023
Q4 		$1.4M Sell
4,432
-217
-5% -$42.2K 0.02% 561
2023
Q3 		$786K Buy
4,649
+29
+0.6% +$5.45K 0.01% 723
2023
Q2 		$1M Buy
4,620
+2,771
+150% +$594K 0.01% 646
2023
Q1 		$336K Buy
1,849
+121
+7% +$23.1K ﹤0.01% 1017
2022
Q4 		$340K Buy
1,728
+54
+3% +$11.6K 0.01% 1008
2022
Q3 		$377K Buy
+1,674
New +$339K 0.01% 931

Other funds holding KRTX

IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
S
Sachetta Lynnfield, Massachusetts $206M AUM 26.19% 1-Year Est. Return

Xponance's KRTX Position: Q1 2024 in Review

Xponance sold out of Karuna Therapeutics, Inc. Common Stock (KRTX) in Q1 2024, closing a stake of 4,432 shares — an estimated $1.4M sold.

Xponance first reported a position in KRTX in Q3 2022 and held it in 6 quarters. The position peaked at $1.4M in Q4 2023. 2 funds tracked by Wall St. Rank hold KRTX as of Q1 2024.

  • Xponance reported no remaining Karuna Therapeutics, Inc. Common Stock position as of Q1 2024 after selling out during the quarter.
  • Xponance sold 4,432 Karuna Therapeutics, Inc. Common Stock shares in Q1 2024, an estimated $1.4M.
  • Xponance first reported a position in Karuna Therapeutics, Inc. Common Stock in Q3 2022 and held it in 6 quarters.
  • Xponance's Karuna Therapeutics, Inc. Common Stock position peaked at $1.4M in Q4 2023.
  • 2 funds tracked by Wall St. Rank held Karuna Therapeutics, Inc. Common Stock as of Q1 2024.

Based on Xponance's 13F filing for Q1 2024, filed 13 May 2024.